Doctors Note Logo

Published on: 9/15/2026

What dose of NAD+ and glutathione should I take together?

Common supplement protocols pair a NAD+ precursor such as nicotinamide riboside or NMN at roughly 250 to 500 mg daily with liposomal or reduced glutathione at about 250 to 500 mg daily, usually taken in the morning on an empty stomach, while IV or injectable protocols use very different amounts on a clinician-set schedule. There is no single officially established combined dose, and the right amount varies with your age, liver and kidney function, existing medications, and whether you are addressing fatigue, oxidative stress, or recovery, so several factors need to be weighed before you start. Timing, cycling, and warning signs of taking too much are covered below, along with details you should review before choosing a dose.

Because dosing depends heavily on your own symptoms and health history, it helps to clarify what your body is actually signaling before adding stacked supplements. You can take a free, instant, online symptom check to better understand what may be driving how you feel and get guidance on sensible next steps.

Last reviewed for medical accuracy: 09/14/2026

answer background

Explanation

NAD+ and Glutathione Synergy: Finding the Right Dose

NAD+ (nicotinamide adenine dinucleotide) and glutathione are two key molecules that support cellular energy, DNA repair and antioxidant defense. When used together, they can reinforce each other’s benefits—often referred to as NAD+ and glutathione synergy. Below is a practical guide to dosing both safely, based on clinical data and expert consensus.


Understanding the Players

  • NAD+

    • A coenzyme found in every cell
    • Essential for energy (ATP) production, DNA repair and healthy aging
    • Levels decline with age, stress and illness
  • Glutathione

    • The body’s master antioxidant
    • Neutralizes free radicals and supports detoxification
    • Exists in a reduced form (GSH) and can be recycled

Clinical studies show that boosting NAD+ can help cells generate more energy, while adequate glutathione prevents oxidative damage. Together they support mitochondrial health and resilience.


Typical Dosing Strategies

1. Oral Supplementation

Supplement Common Dose Notes
NAD+ Precursors NR 250–500 mg once or twice daily
NMN 250–300 mg once or twice daily
Split doses with meals to improve absorption.
Reduced Glutathione (GSH) 250–500 mg once daily
Up to 500 mg twice daily in high-stress situations
Liposomal forms may boost bioavailability.
N-Acetyl Cysteine (NAC) 600 mg twice daily Precursor to glutathione; alternative if GSH not tolerated.

2. Intravenous (IV) Protocols

Protocol Component Dose Range Frequency
NAD+ 100–300 mg per infusion Weekly to monthly, depending on goals
Glutathione (GSH) 600–2,400 mg per infusion Often paired with NAD+

IV therapy is typically administered under medical supervision and may offer faster, more complete absorption.


Guidelines for Combined Use

When pairing NAD+ and glutathione:

  1. Start Low and Go Slow

    • Begin with the lower end of each dosing range.
    • Monitor for side effects (headache, nausea, GI upset).
  2. Split Doses

    • For oral supplements, take once in the morning and once in the afternoon.
    • Improves steady-state levels and tolerability.
  3. Maintain Balance

    • Avoid excessively high doses of one nutrient at the expense of the other.
    • A typical daily oral starter plan:
      • NR 250 mg + GSH 250 mg (morning)
      • NR 250 mg + GSH 250 mg (afternoon)
  4. Cycle or Adjust

    • After 4–8 weeks, re-evaluate your energy levels, sleep quality and lab markers (if available).
    • Increase gradually (e.g., bump NR to 500 mg twice daily or GSH to 500 mg twice daily) if well tolerated.

Safety and Monitoring

  • Side Effects
    • NAD+: flushing, headache, mild nausea
    • Glutathione: bloating, loose stool (especially at higher doses)
  • Precautions
    • If you have asthma, eczema or known allergies, start even more conservatively.
    • High doses of glutathione may interact with chemotherapy or immunosuppressive drugs.
    • IV treatments should be overseen by qualified healthcare providers.

Whenever starting a new supplement regimen, keep a journal of any changes in energy, mood or digestion. This helps you and your doctor fine-tune doses.


Supporting Nutrients and Lifestyle

To maximize NAD+ and glutathione synergy, consider:

  • B-Complex Vitamins
    • B3 (niacin), B2 (riboflavin) and B6 support NAD+ synthesis.
  • Vitamin C
    • Regenerates oxidized glutathione back to its active form.
  • Alpha-Lipoic Acid
    • Another antioxidant that works well alongside glutathione.
  • Lifestyle Habits
    • Regular exercise, quality sleep and a whole-food diet rich in fruits and vegetables help sustain both NAD+ and glutathione naturally.

When to Seek Medical Advice

While many people tolerate these supplements well, certain symptoms warrant prompt attention. If you experience:

  • Persistent chest pain or severe headache
  • Sudden breathing difficulty
  • Signs of an allergic reaction (hives, swelling)

…you should seek emergency care immediately. For non-emergency concerns—such as chronic fatigue, unexplained weight change or digestive disturbances—you might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Key Takeaways

  • NAD+ and glutathione work together to support energy, repair and antioxidant defense.
  • Oral dosing typically starts at NR 250–500 mg/day + GSH 250–500 mg/day.
  • IV protocols often use NAD+ 100–300 mg + GSH 600–2,400 mg per infusion.
  • Begin with lower doses, split intake, and monitor for side effects.
  • Pair with B vitamins, vitamin C and healthy lifestyle habits.

This guide provides a framework, but individual needs vary. Always speak to a doctor before beginning or adjusting any supplement regimen—especially if you have underlying health conditions or take prescription medications.

(References)

  • * Sperry JF, Robertson DC. Erythritol catabolism by Brucella abortus. J Bacteriol. 1975 Feb;121(2):619-30. doi: 10.1128/jb.121.2.619-630.1975. PMID: 163226; PMCID: PMC245974.

  • * ROST J, RAPOPORT S. REDUCTION-POTENTIAL OF GLUTATHIONE. Nature. 1964 Jan 11;201:185. doi: 10.1038/201185a0. PMID: 14118271.

  • * Janků M, Tichá T, Luhová L, Petřivalský M. Measurement of S-Nitrosoglutathione Reductase Activity in Plants. Methods Mol Biol. 2020;2057:45-59. doi: 10.1007/978-1-4939-9790-9_5. PMID: 31595469.

  • * Kang SO, Kwak MK. Alcohol dehydrogenase 1 and NAD(H)-linked methylglyoxal oxidoreductase reciprocally regulate glutathione-dependent enzyme activities in Candida albicans. J Microbiol. 2021 Jan;59(1):76-91. doi: 10.1007/s12275-021-0552-7. Epub 2020 Dec 23. PMID: 33355888.

  • * Aljaser FS, Ghneim HK, ALshubaily MM, Abudawood M, Almajed F, Fatima S, ALsheikh YA. Glutathione and oxidized nicotinamide adenine dinucleotide (NAD(+)) redox status in plasma and placental tissue of Saudi patients with intrauterine growth restriction. Saudi Med J. 2021 May;42(5):491-498. doi: 10.15537/smj.2021.42.5.20200685. PMID: 33896778; PMCID: PMC9149688.

  • * Oka SI, Byun J, Huang CY, Imai N, Ralda G, Zhai P, Xu X, Kashyap S, Warren JS, Alan Maschek J, Tippetts TS, Tong M, Venkatesh S, Ikeda Y, Mizushima W, Kashihara T, Sadoshima J. Nampt Potentiates Antioxidant Defense in Diabetic Cardiomyopathy. Circ Res. 2021 Jun 25;129(1):114-130. doi: 10.1161/CIRCRESAHA.120.317943. Epub 2021 Apr 30. PMID: 33928788; PMCID: PMC8513534.

  • * Ma Y, Zhu S, Yi M, Zhang W, Xue Y, Liu X, Deng H. Profiling Glutathionylome in CD38-Mediated Epithelial-Mesenchymal Transition. J Proteome Res. 2022 May 6;21(5):1240-1250. doi: 10.1021/acs.jproteome.1c00893. Epub 2022 Apr 14. PMID: 35420434.

  • * Yang M, Tsui MG, Tsang JKW, Goit RK, Yao KM, So KF, Lam WC, Lo ACY. Involvement of FSP1-CoQ(10)-NADH and GSH-GPx-4 pathways in retinal pigment epithelium ferroptosis. Cell Death Dis. 2022 May 18;13(5):468. doi: 10.1038/s41419-022-04924-4. Epub 2022 May 18. PMID: 35585057; PMCID: PMC9117320.

  • * Nakamura T, Hipp C, Santos Dias Mourão A, Borggräfe J, Aldrovandi M, Henkelmann B, Wanninger J, Mishima E, Lytton E, Emler D, Proneth B, Sattler M, Conrad M. Phase separation of FSP1 promotes ferroptosis. Nature. 2023 Jul;619(7969):371-377. doi: 10.1038/s41586-023-06255-6. Epub 2023 Jun 28. PMID: 37380771; PMCID: PMC10338336.

  • * Lawal TA, Riekhof W, Groom L, Varma P, Chrismer IC, Kokkinis A, Grunseich C, Witherspoon JW, Razaqyar MS, Sinaii N, Meilleur KG, Xiang L, Buzkova J, Euro L, Mohassel P, Dirksen RT, Todd JJ. NAD(+) dyshomeostasis in RYR1-related myopathies. Skelet Muscle. 2025 Aug 22;15(1):22. doi: 10.1186/s13395-025-00390-6. Epub 2025 Aug 22. PMID: 40846977; PMCID: PMC12374369.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.